Patent ID: 11905565
Assignee: TORAY INDUSTRIES, INC.
Field: Biotechnology (Chemistry)
Classification: CPC C | IPC C

Claim 0:
1. A method for detecting prostate cancer and then treating or performing a diagnostic procedure in a human subject, comprising:
measuring an expression level of hsa-miR-1185-2-3p in a blood, serum, or plasma sample from the subject;
comparing the measured expression level of hsa-miR-1185-2-3p to a control expression level in a sample from a healthy subject; and
detecting an increased level of hsa-miR-1185-2-3p in the sample from the subject as compared to the control expression level from the sample from the healthy subject;
wherein the increased level of hsa-miR-1185-2-3p indicates that the subject has prostate cancer;
and further treating the subject for the prostate cancer or performing a diagnostic procedure on the subject with the prostate cancer;
wherein the treating comprises surgery, radiotherapy, chemotherapy or a combination thereof; and
wherein the diagnostic procedure comprises rectal examination, transrectal ultrasonography of the prostate, or imaging of prostate tissue.